A multicenter, randomized, double-blind, dose parallel, placebo-controlled phase II clinical trial to evaluate the efficacy and safety of Jiaweimojie tablet in the treatment of primary dysmenorrhea with qi-stagnation and blood stasis syndrome

Category Primary study
Registry of TrialsInternational Traditional Medicine Clinical Trial Registry
Year 2021
This article has no abstract
Epistemonikos ID: 7a2556e8f2db03d642525581790cbc46dd1189c4
First added on: Apr 11, 2025